ORGANOGENESIS HOLDINGS INC. Deferred Tax Assets, Operating Loss Carryforwards, Domestic
ORGANOGENESIS HOLDINGS INC. (ORGO) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $4.12 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $4.12M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $2.46M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $9.33M.
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $21.76M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $4.12M 10-K · filed 2026-02-26 |
| 2023-12-31 | $2.46M 10-K · filed 2025-02-27 |
| 2022-12-31 | $9.33M 10-K · filed 2024-02-29 |
| 2021-12-31 | $21.76M 10-K · filed 2023-03-01 |
| 2020-12-31 | $31.78M 10-K · filed 2022-03-01 |
| 2019-12-31 | $36.51M 10-K · filed 2021-03-16 |
| 2018-12-31 | $34.71M 10-K · filed 2020-03-09 |
| 2017-12-31 | $26.73M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |